Universal Biosensors Inc (UBI.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 663 | 649 | 588 | 588 | 594 |
| Accounts receivable | 161 | -90 | -567 | 100 | -82 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 73 | -47 |
| Other Working Capital | -1,556 | -883 | -2,332 | 345 | -2,167 |
| Other Operating Activity | -3,213 | -1,914 | -920 | -774 | -1,733 |
| Operating Cash Flow | $-3,945 | $-2,238 | $-3,230 | $332 | $-3,435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -155 | -170 | -151 | -129 | -65 |
| Other Investing Activity | 0 | 0 | 0 | 15 | 0 |
| Investing Cash Flow | $-155 | $-170 | $-151 | $-114 | $-65 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 20 | 0 | 0 |
| Other Financing Activity | 1 | 62 | 2 | 0 | 0 |
| Financing Cash Flow | $1 | $63 | $23 | $0 | $0 |
| Exchange Rate Effect | 289 | 68 | 90 | -557 | -252 |
| Beginning Cash Position | 22,510 | 24,787 | 28,055 | 28,394 | 32,146 |
| End Cash Position | 18,699 | 22,510 | 24,787 | 28,055 | 28,394 |
| Net Cash Flow | $-4,099 | $-2,346 | $-3,358 | $218 | $-3,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,945 | -2,238 | -3,230 | 332 | -3,435 |
| Capital Expenditure | -155 | -170 | -151 | -129 | -65 |
| Free Cash Flow | -4,100 | -2,408 | -3,380 | 203 | -3,500 |